PMS21 - BUDGET IMPACT MODEL OF INCLUSION OF TOFACITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN FRANCE
Autor: | Masia, C., Pignata, M., Granghaud, A., Ben Chaabane, H., Huyghe Garassus, C., Dubanchet, A., Roze, S. |
---|---|
Zdroj: | In Value in Health October 2018 21 Supplement 3:S291-S291 |
Databáze: | ScienceDirect |
Externí odkaz: |